Latest News

 Filter by Provider

Shares of memory chips maker Micron (NYSE:MU) jumped 5.3% in the afternoon session after several positive analyst actions and broad strength in the semiconductor sector lifted investor sentiment. GF Securities significantly raised its price target on the company's shares to $311 from $194. Adding to the bullish mood, UBS also increased its price target to $245, pointing to a strong demand environment and shortages in the supply of DRAM memory chips. The positive outlook was not limited to Micron. A strong quarterly report from competitor SK Hynix suggested an accelerating upcycle in the memory market. This view was supported by data from the Semiconductor Industry Association, which showed global semiconductor sales grew nearly 16% in the third quarter compared to the second quarter, signaling growing demand for memory and storage hardware.

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an announcement about a new, early-stage study. 

Shares of electricity generation and hydrogen production company Bloom Energy (NYSE:BE) jumped 5.7% in the afternoon session after the company built on recent positive momentum as it forged a multi-billion dollar partnership and reported strong quarterly results. Bloom Energy entered a $5 billion partnership with Brookfield Asset Management to build AI factories powered by its fuel cell technology. This deal was seen as a strong endorsement of its technology. Adding to the good news, the company delivered its fourth straight quarter of record revenues in the third quarter, with sales soaring 57% year over year. To meet the rising demand, Bloom Energy also planned to double its manufacturing capacity by the end of 2026. In response to these developments, several analysts raised their price targets on the stock, including firms like Susquehanna, J.P. Morgan, and HSBC.

Shares of pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) jumped 19.3% in the afternoon session after the company reported strong third-quarter 2025 financial results that surpassed analyst expectations and raised its full-year outlook. 

Shares of pet food company Freshpet (NASDAQ:FRPT) jumped 12.1% in the afternoon session after the company reported third-quarter financial results that significantly surpassed Wall Street's profit expectations. Net sales for the quarter rose 14% year-over-year to $288.8 million, exceeding analyst forecasts. The company's earnings per share (EPS) came in at $1.86, which was substantially higher than the average analyst forecast of $0.42. This large increase in profit was primarily due to a one-time deferred tax benefit of $77.9 million. Freshpet also reported strong volume growth of 12.9% and an improved operating margin, which rose to 8.6% from 4.7% in the same period last year. The company generated positive free cash flow of $31.56 million for the quarter.

March NY world sugar #11 (SBH26 ) is up +0.25 (+1.73%), and December London ICE white sugar #5 (SWZ25 ) is up +8.10 (+1.95%). Sugar prices today posted a new 1-week high as short-covering continued from last week's lows. Last Thursday, NY sugar poste...

The rapid expansion of autonomous vehicle technologies, spearheaded by industry leader Waymo (NASDAQ: GOOGL), is igniting an unprecedented surge in demand for advanced artificial intelligence chips. As Waymo aggressively scales its robotaxi services across new urban landscapes, the foundational hardware enabling these self-driving capabilities is undergoing a transformative evolution, pushing the boundaries of semiconductor innovation. [...]

Buenos Aires, Argentina – In a compelling testament to the transformative power of decentralized finance, Argentina has emerged as a global frontrunner in Bitcoin (BTC) adoption. Faced with relentless hyperinflation, stringent capital controls, and a deep-seated distrust in traditional financial institutions, Argentines are increasingly turning to Bitcoin not merely as a speculative asset, but as [...]

Tesla stock climbed more than 3% to $470.38 in early trading on Monday, placing it within 4% of its all-time high of $488.54 reached in December 2024.

As November 3, 2025 dawns, the global stock market continues its relentless, AI-fueled ascent, with major indices like the S&P 500 and Nasdaq Composite achieving significant new highs. This rally is overwhelmingly concentrated in a handful of technology giants, affectionately dubbed the "Magnificent Seven," alongside other AI-centric firms, collectively

November 3, 2025 – The cryptocurrency market experienced a sharp and sudden downturn today, as major digital assets including Bitcoin (BTC), Ethereum (ETH), Solana (SOL), and XRP plummeted by approximately 5% or more. This significant correction, coming on the heels of a challenging October, has sent ripples of concern throughout the global crypto ecosystem, wiping [...]

October sales were cut nearly in half in Norway and the Netherlands, and fell by about a third in Spain.

Investors remain lukewarm on Berkshire Hathaway stock as they sense Warren Buffett may be bracing for a bear market.

Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook.

Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.

Recent earnings results highlight these companies as big-time AI winners.

Shares of household products company Kimberly-Clark (NYSE:KMB) fell 12.6% in the afternoon session after it announced a deal to acquire consumer health company Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion. The deal involved both cash and stock, which meant that the ownership stake for existing Kimberly-Clark shareholders was set to be diluted; they were expected to own about 54% of the combined company. The market's harsh reaction also seemed tied to Kenvue's significant legal troubles. The maker of Tylenol and Band-Aid faced lawsuits, including allegations linking Tylenol to autism and legal action over talc cancer claims. These existing issues appeared to raise concerns among investors about the risks Kimberly-Clark was taking on. Adding to the uncertainty, an investor rights law firm launched an investigation into whether the merger was fair to Kimberly-Clark's shareholders.

Shares of live sports and TV streaming service fuboTV (NYSE:FUBO) fell 10.6% in the afternoon session after the company reported third-quarter results that showed declining revenue and a significant increase in cash burn, even as it surpassed Wall Street's earnings and sales estimates. 

Shares of car rental services provider Avis (NASDAQ:CAR) fell 1.5% in the afternoon session after an analyst at Barclays lowered the price target on the stock. The analyst, Dan Levy, kept an 'Equal-Weight' rating on the shares but cut the price target by 20%, from $150 down to $120. A lower price target from an analyst can sometimes cause investors to worry about a company's future prospects, which can lead them to sell shares. This adjustment signaled a less optimistic outlook on the stock's potential value.

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.7% in the afternoon session after it rebounded from a steep sell-off that was triggered by its long-term revenue growth outlook. The stock had previously plunged more than 14% after the company's interim CEO stated during its third-quarter earnings call that revenue growth for 2026 could fall short of analyst expectations. This cautious forecast overshadowed an otherwise strong report, in which the company beat third-quarter earnings and revenue estimates. DexCom also raised its full-year 2025 revenue outlook. The sharp drop in previous sessions suggested investors focused more on the future growth warning than the positive current results, and the subsequent modest gain indicated some bargain hunting.

Shares of online fashion resale marketplace ThredUp (NASDAQ:TDUP) fell 6.1% in the afternoon session after investors appeared to show some nervousness ahead of its third-quarter earnings report. The online fashion resale marketplace was expected to report a significant year-over-year revenue increase of about 26.2%, reaching approximately $77.6 million. Analysts' forecasts called for an adjusted loss between $0.04 and $0.05 per share. The stock's decline suggested some uncertainty among investors as they waited for the official results and any forward-looking guidance the company might provide.

Shares of semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) jumped 15.5% in the afternoon session after Aletheia Capital initiated coverage on the company with a 'Buy' rating and a $62 price target. The firm highlighted Amkor's position as a leading U.S.-based provider for semiconductor assembly and testing. The positive outlook was based on rising demand for advanced chip packaging, known as CoWoS, and the America Manufacturing initiative. Aletheia Capital projected significant growth in the company's CoWoS sales and earnings per share over the next few years. The bullish analyst coverage was supported by Amkor's third-quarter financial results, where both revenue and profit exceeded Wall Street's expectations. The company reported revenue of $1.99 billion and earnings per share of $0.51, beating estimates. However, its revenue guidance for the fourth quarter was slightly below analyst forecasts.

Shares of insurance data analytics provider Verisk Analytics (NASDAQ:VRSK) fell 1.9% in the afternoon session after its Extreme Event Solutions group announced an estimate for industry-insured losses in Jamaica from Hurricane Melissa, projecting a range between $2.2 billion and $4.2 billion. The estimate covered onshore properties and noted that most of the modeled loss was due to wind damage. This news likely added to investor concerns, as it followed a recent update where Verisk had lowered its full-year 2025 revenue guidance. The company had cited softer demand stemming from unusually mild weather and a reduced government contract for the lowered outlook.

Shares of auto parts and accessories retailer O’Reilly Automotive (NASDAQ:ORLY) fell 3.8% in the afternoon session after investors continued to sell shares following its recent quarterly earnings report, which contained a weak full-year guidance. 

Shares of asset management company Affiliated Managers Group (NYSE:AMG) jumped 6.2% in the afternoon session after the company reported third-quarter results that showed a significant increase in profitability, despite a slight miss on revenue. 

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The rating, which was reiterated, signaled continued caution from the investment bank. An 'Underweight' recommendation suggests that an analyst believes the stock might perform worse than other stocks in its industry. This continued negative view from a major bank likely weighed on investor sentiment. The action came amid broader concerns regarding the company's performance, including slowing earnings growth and retreating profit margins.

Shares of security systems manufacturer Napco (NASDAQ:NSSC) fell 10.5% in the afternoon session after the company reported underwhelming earnings. For its third quarter, Napco's revenue grew 11.7% year on year to $49.17 million, surpassing Wall Street's forecasts. Earnings per share came in at $0.34, which was also higher than the $0.31 per share that analysts had forecast. Despite the strong report, the stock's drop followed a significant increase in its price, which included a surge of over 87% over the previous six months and hitting a new 52-week high. This performance suggested that investors' high expectations were already reflected in the share price before the announcement, leading to a "sell the news" reaction.

Shares of recreational products manufacturer American Outdoor Brands (NASDAQ:AOUT) fell 1.5% in the morning session after the stock hit a new 52-week low amid ongoing concerns about its financial performance. The shares reached a low of $6.70, reflecting persistent challenges for the company. Financial metrics highlighted these struggles, including a negative return on equity of -2.71% and a significant decline in operating profit over the previous five years. The stock also showed weak momentum, with a relative price strength that was considered poor. This move happened during a mixed trading session where the majority of stocks in the broader market were also falling.

Shares of cable, internet, and telephone services provider Charter (NASDAQ:CHTR) fell 5.6% in the afternoon session after the stock's negative momentum continued as the company reported disappointing third-quarter 2025 financial results, which missed analyst expectations and revealed a significant loss in internet customers. The cable and broadband provider announced earnings per share of $8.34, falling short of the $9.27 analysts had predicted. Revenue also came in slightly below forecasts at $13.67 billion. A key point of concern was the loss of 109,000 internet customers during the quarter, a larger decline than the 83,000 that Wall Street had anticipated. The company’s CEO noted that tough competition from fixed wireless and fiber providers was a major factor. Adding to the pressure, Wells Fargo lowered its price target on the stock by 20% to $240 from $300, although it kept its "Equal-Weight" rating.

Shares of travel technology company Sabre (NASDAQ:SABR) fell 2.2% in the afternoon session after the stock extended recent losses amid a broader negative trend. The move followed a period of significant underperformance. Over the preceding year, the share price had dropped 40%, and it was down 35% in about a quarter. This decline continued a challenging five-year period for investors, during which the stock had lost 75% of its value, reflecting persistent negative sentiment.

Shares of telecommunications and media company Comcast (NASDAQ:CMCSA) fell 3% in the afternoon session after a series of analyst price target reductions and a recent ratings downgrade driven by concerns over its broadband business. On November 3, Barclays lowered its price target on the stock to $30 from $34, while Deutsche Bank also adjusted its target down to $40 from $44. These actions followed a ratings downgrade from Seaport Global, which moved the stock to "Neutral" from "Buy." Analysts voiced worries after the company warned it would likely face more customer losses in its broadband division due to rising competition from fiber and fixed wireless providers.

Shares of railway infrastructure company L.B. Foster (NASDAQ:FSTR) fell 1.2% in the afternoon session after the company reported third-quarter financial results that missed Wall Street's expectations and lowered its full-year revenue forecast. 

Shares of packaged foods company Kraft Heinz (NASDAQ:KHC) fell 2.5% in the afternoon session after the stock's negative momentum continued as the company reported mixed third-quarter results and multiple analysts lowered their price targets on the stock. The food and beverage company's overall sales declined 2.3% year-over-year to $6.2 billion, falling short of expectations. The report prompted negative commentary from the analyst community. For instance, a TD Cowen analyst reiterated a “Hold” rating and reduced the price target from $28 to $26. Similarly, a Barclays analyst maintained an 'Equal-Weight' rating while lowering the price target from $26.00 to $24.00. This move extended a challenging period for the company, as the stock had already seen a significant decline over the previous year.

Shares of digital insurance provider Lemonade (NYSE:LMND) jumped 3.5% in the afternoon session after investors grew optimistic about its upcoming third-quarter earnings report, with sentiment also boosted by a broader market rally. The company was scheduled to report its results on November 5. Ahead of the announcement, reports indicated expectations for strong top-line growth. Estimates pointed to a potential revenue increase of between 35% and 38% compared to the same period in the previous year.

Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen downgraded its rating on the stock from Buy to Hold. The firm cited valuation concerns as the main reason for the change, noting that IQVIA's current stock price already reflected its growth outlook. Analysts also pointed to "generally subdued market conditions and margin pressures" as factors that limited the potential for further gains. While TD Cowen did raise its price target on the shares to $215 from $206, the downgrade signaled caution. The negative sentiment from this rating change appeared to outweigh a more positive view from Morgan Stanley, which maintained its Overweight rating and raised its price target on the same day.

Roger Carlile appointed as RGP's President and CEO, succeeding Kate Duchene who stepped down. Carlile has been a board member since 2024.

Nvidia's (NASDAQ: NVDA) strategic pivot towards localizing the production of its cutting-edge artificial intelligence (AI) chips within the United States, particularly through significant investments in Arizona, marks a watershed moment in the global technology landscape. This bold initiative, driven by a confluence of surging AI demand, national security imperatives, and a push for supply chain [...]

The cryptocurrency market, ever-evolving and rife with opportunities, is constantly on the hunt for the next big breakout. As of late 2025, investors and enthusiasts are increasingly turning their attention to emerging, currently inexpensive cryptocurrencies, asking a pivotal question: could any of these nascent projects replicate the meteoric rise of Cardano (ADA)? This quest for [...]

The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This monumental $48.7 billion cash-and-stock deal, announced on November 3, 2025, has sent positive ripples through the stock market, particularly benefiting

Yields are ascending in relative uniformity across the curve, but duration is leading the bear-steepening rise, albeit modestly.

Key features of Archer's business strategy could help the company eventually eclipse the valuation of rival Joby.

Bitcoin's much-anticipated "Uptober" trend, a historical period of positive monthly performance, concluded with an unexpected downturn in October 2025. For the first time in seven years, the cryptocurrency closed the month in the red, marking a significant deviation from its usual bullish October trajectory. This reversal has sent ripples through the crypto market, prompting renewed [...]

As of November 2025, the global financial landscape is marked by a profound divergence in stock market performance, largely orchestrated by the accelerating influence of Artificial Intelligence (AI) deals and investments. While a select cohort of tech giants and their respective markets are soaring to unprecedented heights, propelled by an

Phoenix, AZ – November 3, 2025 – Taiwan Semiconductor Manufacturing Company (TSMC) (NYSE: TSM) is dramatically reshaping the landscape of advanced semiconductor manufacturing in the United States, cementing its pivotal role in bolstering American capabilities, particularly in the burgeoning field of artificial intelligence. With an unprecedented commitment now reaching US$165 billion, TSMC's expanded investment in [...]

CrowdStrike Holdings Inc (NASDAQ:CRWD) shares are rising on Monday. Here's a look at what's driving the action.

November 3, 2025 – In a move that sent ripples of confusion and concern through the digital asset landscape, cryptocurrency investment products registered a staggering $360 million in outflows in the week leading up to November 3, 2025. This significant capital flight occurred despite the U.S. Federal Reserve's decision to cut interest rates by 25 [...]

India is aggressively pushing to establish itself as a formidable global player in semiconductor manufacturing, moving strategically from being a major consumer to a significant producer of chips. This national drive, underscored by substantial investments and strategic initiatives, aims to achieve digital sovereignty, enhance economic resilience, and secure India's position in critical global technology supply [...]

Chevron reported a 52% rise in Q3 adjusted free cash flow - more than covering its dividend and buybacks. This implies that if Chevron raises its dividend by 5%, CVX stock may be worth $171 per share, up +10%.

The cryptocurrency ecosystem is grappling with a severe and escalating crisis: a dramatic surge in scams, particularly those leveraging Bitcoin ATMs to defraud vulnerable senior citizens. As of late 2025, alarming statistics reveal billions of dollars in losses, with older adults disproportionately targeted, suffering devastating financial and emotional consequences. This pervasive fraud not only wipes [...]

The chipmaker's shares hit new records on lots of good news, and there's plenty to be excited about for the future.